Act1 is a negative regulator in T and B cells via direct inhibition of STAT3

Journal: Nature Communications

Published: 2018-07-16

DOI: 10.1038/s41467-018-04974-3

Affiliations: 17

Authors: 24

Go to article
Institutions FC
Department of Inflammation and Immunity, Cleveland Clinic, United States of America (USA) 0.46
BMS Princeton, United States of America (USA) 0.13
Department of General Rheumatology, Cleveland Clinic, United States of America (USA) 0.08
Novo Nordisk A/S, Denmark 0.04
NIH NHLBI Laboratory of Molecular Immunology, United States of America (USA) 0.04
UNC Department of Medicine, United States of America (USA) 0.03
UNC Center for Gastrointestinal Biology and Disease (CGIBD), United States of America (USA) 0.03
Institute of Radiation Medicine (IRM), CAMS & PUMC, China 0.02
Tianjin Neurological Institute at the General Hospital, TMU, China 0.02
Beijing Tiantan Hospital, Capital Medical University, China 0.02
Department of Surgery, Mizzou, United States of America (USA) 0.02
Department Molecular Microbiology and Immunology (MMI), Mizzou, United States of America (USA) 0.02
Department of Neurology at the General Hospital, TMU, China 0.02
Wuhan Institute of Biotechnology, China 0.01
UNC Department of Microbiology and Immunology, United States of America (USA) 0.01
MOE Key Laboratory of Molecular Biophysics, HUST, China 0.01
Department of Neurology, SJHMC, United States of America (USA) 0.01

Return